Remove 2019 Remove Diabetes Remove Hospital Remove Management
article thumbnail

Key Facts GPs Should Know About GLP-1 Analogs

Family Medicine Initiative

4 Chronic Kidney Disease The FLOW trial randomized 3,534 patients with chronic kidney disease and type 2 diabetes and started treating them with s.c. mg or placebo in 2019. Both the FDA and EMA recommend that doctors monitor patients with diabetic retinopathy who are undergoing semaglutide treatment closely. semaglutide 1.0

Diabetes 130
article thumbnail

Outcomes associated with timing of screening for gestational diabetes [Women's health]

Annals of Family Medicine

Context: Screening for gestational diabetes (GDM) at recommended times, based on a pregnant woman’s risk for GDM, is important in order to initiate and optimize the management of GDM as early as possible, thus mitigating the risk of several adverse outcomes for both pregnant women and their offspring.

Screening 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Preemies receive sucrose for pain relief—new research shows it doesn't stop long-term impacts on development

Medical Xpress

The commonest strategy to manage acute pain in preterm babies is to give them sucrose , a sugar solution. One of these sites does not use sucrose for acute pain management. We found no link between preterm babies later behavior and how much sucrose they were given to manage pain. Whats more, pain isnt always managed.

IT 53
article thumbnail

Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities

FDA Law Blog

A final OIG rule to change the structure of manufacturer rebates to Medicare Part D and Medicaid Managed Care plans and their PBMs is enmeshed in litigation and is likely to be at least postponed until 2026 (see our post ), and perhaps prevented from implementation altogether, by Congressional mandate.